Venture capitalists seeking to revolutionise cancer treatment and testing helped propel biomedical venture capital investment to new heights in 2019.
In an analysis of US medical venture funding across 17 areas of the human body, the industry set records in both the blood and immune system categories, largely because of interest in new ways of detecting cancer in the blood and harnessing immune cells’ tumour fighting powers.
Image: https://www.penews.com
